B+
Bull case
30%
Probability
Target price
$500.00
Analysis reference price unavailable
Analysis 2026-10-22 · RankAlpha Sentiment Codex
ELV
Elevance HealthBNYSE / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
The Q3 adjusted EPS and revenue beat, 70-basis-point benefit-expense-ratio improvement, and increase in FY2026 adjusted EPS guidance to at least $29 support a more constructive view than the prior neutral baseline. Carelon growth and the reiterated 2027 growth objective provide a path to further upside, conditional on recurring operating gains [#SEC-8K-2026-10-21].
Posture
Constructive
Lead driver
Value
What changed
6 setup hits (3d) with net bullish as of 2026-10-26.
What can break
A $1.85-per-share net non-operating benefit makes reported adjusted EPS less representative of recurring operating earnings [#SEC-8K-2026-10-21].
Momentum
74
Value
64
Sentiment
50
Setup hits (3d)
6 · Net Bullish
AI TargetsBase $460.00 · Bull $500.00 · Bear $370.00Analysis 2026-10-22; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-26 • Vendor: Data Vendor v1
Scores
As of 2026-10-23 • Model: HYBRID_IC_RP
AI Memo
As of 2026-10-22 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-10-23
Investment thesis
As of 2026-10-23
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-23. Definitions
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Bullish
Target $459.86
Why
Momentum74 · Δ7d +15.5
Value64 · Δ7d -0.0
Sentiment50 · Δ7d +11.8
So what
Strength-led posture (Net Bullish). Favor watchlist adds and disciplined entries.
Confirming evidence
- • 6 setup hits (3d) with net bullish as of 2026-10-26.
- • Value remains the lead driver in the composite, 7D delta -0.0.
Contradictions & invalidation
- • A $1.85-per-share net non-operating benefit makes reported adjusted EPS less representative of recurring operating earnings [#SEC-8K-2026-10-21].
- • Adjusted operating expense ratio rose 90 basis points year over year, partly reflecting targeted investments [#SEC-8K-2026-10-21].
- • The $1.85-per-share non-operating benefit clouds the quality of the EPS beat.
Catalyst clock
2026-11-15
Post-print reassessment of a qualified Q3 beat
Lead driver: Value · See fundamentals
Momentum
74
8% active weight
Current posture
7d trendImproving
Δ7d
+15.5
Δ21d
+11.0
Value
64
47% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
-1.4
Sentiment
50
45% active weight
Current posture
7d trendImproving
Δ7d
+11.8
Δ21d
-7.0
Why this grade
Composite grade B. Momentum 73.8 / Value 63.6 / Sentiment 50.0
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-10-22. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$460.00
Analysis reference price unavailable
Analysis 2026-10-22 · RankAlpha Sentiment Codex
B-
Bear case
20%
Probability
Target price
$370.00
Analysis reference price unavailable
Analysis 2026-10-22 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-10-26
Fundamentals (TTM)
As of 2026-10-26
Market Cap
$93.19B
Beta
0.50
Shares Out
216.06M
P/E (TTM)
14.9
P/S (TTM)
0.41
P/FCF (TTM)
36.79
Rev YoY
+1.4%
EPS YoY
-13.0%
Gross Margin
-
Op Margin
+3.6%
Net Debt
$23.22B
Current Ratio
1.52
As of 2026-10-23 • Updated nightlySource: Internal modelMethods & Data